Literature DB >> 23267282

MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?

Susan Worley.   

Abstract

For so long, multiple sclerosis has frustrated physicians and patients. With bold new treatments on the way, payers are thinking about tighter management. Formal treatment guidelines would help. Bio-markers could also sort out the 'right-drug, right-patient' conundrum.

Entities:  

Year:  2012        PMID： 23267282      PMCID： PMC3524745     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  3 in total

Review 1.  From bench to MS bedside: challenges translating biomarker discovery to clinical practice.

Authors:  Sathyanath Rajasekharan; Amit Bar-Or
Journal:  J Neuroimmunol       Date:  2012-02-29       Impact factor: 3.478

2.  Oral therapy for multiple sclerosis--sea change or incremental step?

Authors:  William M Carroll
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

3.  One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis.

Authors:  L Prosperini; V Gallo; N Petsas; G Borriello; C Pozzilli
Journal:  Eur J Neurol       Date:  2009-06-15       Impact factor: 6.089
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.